Hint mode is switched on Switch off
For swift navigation between sections

INGENIA Therapeutics

PDF download

Choose all Reset all
Download Cancel
Organization name
INGENIA Therapeutics Inc.
Country name
USA
Country of registration
-
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Ingenia Therapeutics Inc. (Reg. S) is a U.S.-headquartered, clinical-stage biotechnology company that made history in August 2026 by completing a milestone initial public offering (IPO) of Korea Depositary Receipts (KDRs) on the KOSDAQ market of the Korea Exchange (KRX), marking the first listing of a U.S.-based company on the exchange in over five years

Awards

Documentation

Stocks

Public debt by currencies

Show more Hide

Codes

  • NACE
    *** ***
  • NAICS
    *** ***
Registration is required to get access.